NUEVA YORK–(BUSINESS WIRE)–Even Realities, la empresa que ha creado las gafas inteligentes sin cámara centradas en la pantalla, ha presentado hoy el modelo Brown 2, una nueva variante de color inspirada en el carey clásico para las Even G2, junto con…
Category: News
Even Realities adopte le motif classique « écaille de tortue » pour ses lunettes connectées avec le nouveau modèle Even G2 Brown 2
NEW YORK–(BUSINESS WIRE)–Even Realities, la société à l’origine des lunettes connectées sans caméra qui privilégient l’affichage d’informations, a dévoilé aujourd’hui Brown 2, une nouvelle déclinaison des Even G2 inspirée du motif écaille de tortue, …
Even Realities bringt mit dem neuen Modell „Even G2 Brown 2“ das klassische Schildpatt-Design auf Smart-Brillen
NEW YORK–(BUSINESS WIRE)–Even Realities, das Unternehmen hinter den kameralosen, displayorientierten Smart-Brillen, hat heute „Brown 2“ vorgestellt, eine neue, von Schildpatt inspirierte Farbvariante für die Even G2, sowie zwei Accessoires: den Even …
Even Realities Brings Classic Tortoiseshell Design to Smart Glasses with New Even G2 Brown 2
NEW YORK–(BUSINESS WIRE)–Even Realities, the company behind camera-free, display-first smart glasses, today introduced Brown 2, a new tortoiseshell-inspired colorway for Even G2, alongside two accessories: Even G2 Clip (Polarized) and the Even G2 Cha…
Researchers Urge Adding Dry Eye Treatment to Menopause Care
Dry eye is common, hormonally mediated, and underrecognized in menopause, and a study argues clinicians should screen for it. Medscape Medical News
Same-Day Cataract Surgery in Both Eyes: Safe, With Caveats
A study of almost 800 people who had cataract surgery in both eyes in one visit found no extraordinary safety issues, but that does not mean it’s suitable for everyone. Medscape Medical News
Dry Eye Disease: 5 Things to Know
Dry eye disease requires targeted, phenotype-directed care beyond basic artificial tears. Discover five key clinical insights on meibomian gland dysfunction and novel water-free therapies. Medscape Ophthalmology
Conference MDAngle ACR 2026 SLE/Lupus Nephritis
Insights from ACR 2026, including anticipated presentations, key takeaways, and how emerging SLE and lupus nephritis research may affect patient care. Medscape
Novel Prediction Tools and New Therapeutic Targets for DPN
Diabetic peripheral neuropathy is among the most common and debilitating complications of type 2 diabetes, but early detection and effective treatments remain challenging. Medscape Medical News
Researchers Perform First Robotic Human Eye Injection
A team based in Switzerland says their robot reacts up to 20 times faster than a human while injecting into the eye. Medscape Medical News
Schirmer Test Performs Poorly but May Have Other Uses
Despite the Schirmer test’s existing limitations, the strips it uses may contain invaluable data for ultimately identifying different endotypes of Sjögren disease. Medscape Medical News
Personalized Care Is the Future of Dry Eye Management
New insights into dry eye disease are advancing personalized care, using underlying causes, targeted diagnostics and treatment to improve outcomes and quality of life. Medscape
Psoriasis and Its Comorbidities: 5 Things to Know
Psoriasis extends beyond the skin. Explore five key comorbidities, from psoriatic arthritis and cardiometabolic risk to mental health and ocular disease, to support comprehensive care. Medscape Dermatology
Study Supports In-Office Retinal Surgeries, but How Complex?
A study shows good outcomes for office-based retinal surgeries typically done in a hospital or ambulatory surgery center, but their complexity may be an open question. Medscape Medical News
A1c: Not as Useful in Practice as One Might Think
Ms Said and Dr Paauw explain several drawbacks of use of A1c in practice. Medscape Internal Medicine
Viral Culprit Behind Unexpected Eye Cases
Herpesviruses may underlie ocular conditions in ways that defy clinicians’ expectations. Medscape Medical News
Study Suggests Walking as a Tonic to Ward Off AMD
A study finds a link between moderate-to-vigorous physical activity and thicker retinal structures, which could help prevent age-related macular degeneration. Medscape Medical News
FDA Approves Ryzumvi Eye Drops for Presbyopia
The medication is currently approved to treat pharmacologically induced mydriasis, or pupil dilation, in adults and children ages 3 years or older. Medscape Medical News
Reformulated Biologic Shows Duration in Diabetic Retinopathy
A trial shows the investigative biologic tarcocimab achieved visual improvements in patients with diabetic retinopathy after a year with a 6-month treatment interval. Medscape Medical News
Trials Suggest Targeting IL-6 in Uveitic Macular Edema
An investigational nonsteroidal treatment for uveitic macular edema shows improvement in vision and retinal thickness at 16 weeks and for up to a year. Medscape Medical News